Issue of Share Options and Director/PDMR Dealing

Quadrise granted 35 million new options, now totaling 5.82% of share capital.

What the company is saying

Quadrise plc is communicating the grant of 35,000,000 new share options to directors and employees under its 2016 Unapproved Share Option Plan and EMI Plan. The company emphasizes that 30,000,000 of these are performance options with a 3.5p exercise price, awarded to incentivize performance and align management with shareholders. The announcement details specific allocations: Peter Borup (8,000,000), Jason Miles (7,000,000), and David Scott (2,500,000), with a total of 17,500,000 options to key executives. The company also granted 5,000,000 nominal value options at 1p, including 1,000,000 to CFO David Scott, as partial compensation for the year ended 30 June 2026, to preserve cash. The tone is factual, highlighting that previous options (10,000,000 and 5,625,000) lapsed unvested due to unmet performance conditions. Chairman Andrew Morrison frames the grants as both a retention tool and a means to conserve cash ahead of commercialisation.

What the data suggests

The company has issued 35,000,000 new options, bringing total outstanding options to 126,162,045, which represents 5.82% of current issued share capital. Of these, 30,000,000 are performance-based with vesting tied to the corporate scorecard for the year ending 30 June 2027; vesting is staggered (25% or 50% per year depending on performance thresholds). 5,000,000 nominal value options at 1p were granted in lieu of cash pay, with 1,000,000 going to the CFO. The lapse of 15,625,000 prior options due to unmet conditions signals that vesting hurdles are meaningful and not automatic. No financial performance data, revenue, or profit figures are disclosed; the only directional signal is the company’s intent to conserve cash. The data is complete and specific for option grants, but does not provide insight into operational or financial trajectory.

Analysis

The announcement is a standard disclosure of share option grants to directors and employees, with all relevant figures, vesting schedules, and allocations clearly stated. The language is factual and does not overstate the significance of the grants; it simply outlines the mechanics and rationale for the awards, including the intention to incentivise performance and preserve cash. While some statements are forward-looking (e.g., vesting contingent on future performance, options intended to incentivise value creation), these are routine for option grants and not promotional in tone. There are no exaggerated claims about imminent financial or operational benefits, and no large capital outlay is disclosed. The only forward-looking elements relate to the vesting conditions and intended alignment of interests, which are standard for such announcements. No measurable progress or financial impact is claimed beyond the grant itself.

Risk flags

• ●The large volume of options granted—now totaling 5.82% of share capital—creates potential dilution risk for existing shareholders if exercised, especially if performance hurdles are met.
• ●Vesting of performance options is contingent on future corporate scorecard outcomes through June 2027, introducing uncertainty as to whether these incentives will actually vest and align with shareholder value creation.
• ●The use of nominal value options in lieu of cash pay signals a need to conserve cash, which may indicate tight liquidity or a desire to minimize outflows ahead of commercialisation; this could be a warning sign if cash constraints persist.

Bottom line

Quadrise’s issuance of 35 million new options, including 30 million performance-based and 5 million nominal value options, increases potential dilution to 5.82% of share capital. The grants are structured to incentivize management and conserve cash, with vesting tied to performance targets through mid-2027. Previous lapses of 15.6 million options show that vesting hurdles are real, not automatic. No operational or financial performance data is disclosed, so investors cannot gauge underlying business momentum from this announcement alone. The key takeaway is that management incentives are now heavily option-based, and the company is prioritizing cash preservation. Investors should focus on future updates regarding commercial progress and cash position to assess whether these incentives will drive real value.

Announcement summary

(AIM:QED) Quadrise plc has announced the grant of an aggregate of 35,000,000 options to subscribe for new ordinary shares of 1p each in the Company to directors and employees under the Company’s Unapproved Share Option Plan 2016 and Enterprise Management Incentive Share Option Plan. Of these, 30,000,000 performance share options have been awarded to executives and employees, including directors and PDMRs, with an exercise price of 3.5p. The award of Performance Options follows the lapse of 10,000,000 share options announced on 13 October 2025 and 5,625,000 share options announced on 27 October 2025, both of which lapsed unvested due to performance conditions not being met. Vesting of the Performance Options will be determined by performance against the Company’s corporate scorecard for the year ending 30 June 2027. If the minimum performance threshold is achieved, 25% of the Performance Options will vest on each of the first and second anniversaries of grant, with the balance lapsing; if the higher performance threshold is achieved, 50% will vest on each of the first and second anniversaries of grant. Performance Options under the EMI plan are exercisable from vesting until the tenth anniversary of grant, and those under the 2016 plan are exercisable from vesting until the eighth anniversary. Director/PDMR allocations are: Peter Borup (8,000,000 options, 2016 Plan, 3.5p), Jason Miles (7,000,000 options, EMI Plan, 3.5p), and David Scott (2,500,000 options, EMI Plan, 3.5p), totaling 17,500,000 options. The Company has also granted 5,000,000 nominal value options (NVOs) with an exercise price of 1p to employees in lieu of cash remuneration for the financial year ended 30 June 2026, under the EMI Plan. The NVOs vest six months from grant, have no performance conditions, and are exercisable until the tenth anniversary of grant. David Scott, Chief Financial Officer, received 1,000,000 NVOs. Following these grants, the Company has a total of 126,162,045 options to subscribe for new ordinary shares in issue, representing approximately 5.82% of the Company’s current issued ordinary share capital. The date of transaction for these awards is 21 September 2026. The options were awarded at nil price. Andrew Morrison, Chairman, stated that the performance options are intended to incentivise achievement of performance objectives and delivery of shareholder value, while the nominal value options are intended to support retention of personnel and preserve cash resources.

Disagree with this article?